# Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort

> **NCT00618176** · PHASE4 · COMPLETED · sponsor: **Peking Union Medical College** · enrollment: 198 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Zidovudine (AZT)+ Didanosine (ddI)+ Nevirapine (NVP)
- **DRUG:** Stavudine (d4T), Lamivudine (3TC), Nevirapine (NVP)
- **DRUG:** Zidovudine (AZT), Lamivudine (3TC), Nevirapine (NVP)

## Key facts

- **NCT ID:** NCT00618176
- **Lead sponsor:** Peking Union Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-09
- **Final completion:** —
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2008-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00618176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00618176, "Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00618176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*